Simultaneous Methylation Profiling of Tumor Suppressor Genes in Head and Neck Cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  DNA and Cell Biology

• Publication date

  2011-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/dna.2010.1090PMID 20860434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA methylation of interferon regulatory factors in gastric cancer and noncancerous gastric mucosae

  2010cited by this paper
• Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.

  2010cited by this paper
• Promoter Methylation of Specific Genes is Associated with the Phenotype and Progression of Colorectal Adenocarcinomas

  2010cited by this paper
• Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids

  2010cited by this paper
• Methylation status of nine tumor suppressor genes in multiple myeloma

  2010cited by this paper
• Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma.

  2009cited by this paper
• Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.

  2009influential reference
• CHFR promoter hypermethylation and reduced CHFR mRNA expression in ovarian cancer.

  2009influential reference
• Association between frequent CpG island methylation and HER2 amplification in human breast cancers.

  2009cited by this paper
• Methylation Profiles in Breast Cancer

  2009influential reference
• Epigenetic modulation of the retinoid X receptor α by green tea in the azoxymethane‐ApcMin/+ mouse model of intestinal cancer

  2009cited by this paper
• Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.

  2009cited by this paper
• The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methylation data with gene expression.

  2008influential reference
• Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.

  2008cited by this paper
• Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma

  2008cited by this paper
• Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping

  2008cited by this paper
• Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma.

  2008cited by this paper
• The epigenomics of cancer.

  2007cited by this paper
• Sequential gene promoter methylation during HPV-induced cervical carcinogenesis

  2007influential reference
• Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer.

  2007cited by this paper
• Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.

  2007cited by this paper
• Hypermethylation of the COX‐2 gene is a potential prognostic marker for cervical cancer

  2007cited by this paper
• Epigenetic gene silencing in cancer: the DNA hypermethylome.

  2007influential reference
• Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer.

  2007cited by this paper
• Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers

  2007cited by this paper
• Insulin-like growth factor-I has different effects on myogenin induction and cell cycle progression in human alveolar and embryonal rhabdomyosarcoma cells.

  2007cited by this paper
• Positive Correlation of Tissue Inhibitor of Metalloproteinase‐3 and Death‐Associated Protein Kinase Hypermethylation in Head and Neck Squamous Cell Carcinoma

  2007cited by this paper
• Recent new approaches to the treatment of head and neck cancer

  2006cited by this paper
• The prognostic impact of O6‐Methylguanine‐DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma

  2006cited by this paper
• Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing

  2006cited by this paper
• The epigenetics of oral cancer.

  2006cited by this paper
• Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer.

  2006cited by this paper
• Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.

  2005cited by this paper
• Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?

  2005cited by this paper
• The tumor suppressor RASSF1A in human carcinogenesis: an update.

  2005cited by this paper
• Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia

  2005influential reference
• Methylation-Specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences

  2005cited by this paper
• The epigenetics of cancer etiology.

  2004cited by this paper
• DNA methylation changes in multiple myeloma

  2004cited by this paper
• DNA‐methylation analysis identifies the E‐cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies

  2004cited by this paper
• O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.

  2004cited by this paper
• Quantitative Multiplex Methylation-Specific PCR Assay for the Detection of Promoter Hypermethylation in Multiple Genes in Breast Cancer

  2004influential reference
• Epigenetic alterations in head and neck cancer: Prevalence, clinical significance, and implications

  2004influential reference
• Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.

  2004cited by this paper
• Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)

  2003cited by this paper
• Early detection: The power and the promise of DNA methylation markers

  2003cited by this paper
• Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.

  2003cited by this paper
• Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors

  2003cited by this paper
• Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

  2003cited by this paper
• DNA methylation and breast carcinogenesis

  2002cited by this paper
• Patterns of gene promoter methylation in squamous cell cancer of the head and neck

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002influential reference
• Behavioural genetics: Worms gang up on bacteria

  2002cited by this paper
• Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma.

  2002influential reference
• DNA methylation analysis: a powerful new tool for lung cancer diagnosis

  2002cited by this paper
• A gene hypermethylation profile of human cancer.

  2001influential reference
• Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.

  2001cited by this paper
• DAP kinase-a proapoptotic gene that functions as a tumor suppressor.

  2001cited by this paper
• Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

  2000cited by this paper
• Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.

  2000cited by this paper
• Alterations in DNA methylation: a fundamental aspect of neoplasia.

  1998cited by this paper
• DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene

  1997cited by this paper

• Methylation Profile of DAPK-1 Between Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma

  2024cites this paper
• An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma

  2021cites this paper
• Endogenous retrovirus HERV-K6 and HERV-K11 polymorphisms’ analyses in head and neck squamous cell carcinoma patients

  2021cites this paper
• Principles of bi-sulfite conversion of DNA and methylation-specific PCR (MSP) in biological research

  2020cites this paper
• Epigenetic Profiling in Head and Neck Cancer

  2019cites this paper
• DNA methylation biomarkers for head and neck squamous cell carcinoma

  2018cites this paper
• The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2

  2017cites this paper
• Copy number profiling of tumor suppressor genes in head and neck cancer

  2017cites this paper
• The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.

  2015cites this paper
• Promoter hypermethylation using 24-gene array in early head and neck cancer

  2014cites this paper
• Histone modifications: Targeting head and neck cancer stem cells.

  2014cites this paper
• Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome

  2014influential citation
• HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation

  2014cites this paper
• MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma

  2012cites this paper
• Promoter methylation and loss of p16INK4a gene expression in head and neck cancer

  2012cites this paper
• CHFR (checkpoint with fork-head associated and ring finger)

  2011cites this paper
• Role of DNA methylation in head and neck cancer

  2011influential citation